Introduction EGFR exon 20 insertion mutation-positive non-small cell lung cancer (NSCLC) is rare, has a poor prognosis, and outcomes are not fully established. We describe and evaluate outcomes from real-world and clinical evidence in these patients. Methods A systematic literature review (SLR) ...
non﹕mall cell lung cancerstomachThe occurrence of gastrointestinal metastasis from lung carcinoma is rare. Compared with non锕昺all cell lung cancer (NSCLC), small cell lung cancer more commonly results in this sort of metastasis. Here, we report an unusual case of NSCLC initially without ...
Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysisMeta-analysisNSCLCVeriStratproteomic testprognosisObjective: Timely assessment of patient-specific prognosis is critical to oncology care involving a shared decision-making ...
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screeni
Non-small-cell lung cancers (NSCLCs), the most common lung cancers, are known to have diverse pathological features. During the past decade, in-depth analyses of lung cancer genomes and signalling pathways have further defined NSCLCs as a group of distinct diseases with genetic and cellular het...
The importance of non-small cell lung cancer (NSCLC) histologic subtype has increased during the last few decades because of an unprecedented shift in epidemiology and an increasing number of target-specific chemotherapeutic agents. This review examined histology as a potential prognostic and/or predict...
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screeni
Two different types of this malignancy include small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC comprises a complex molecular heterogeneity, with many changes in molecular structures and expression frequency. One of these alterations is MYC overexpression due to the gene...
The Humanistic Burden of Small Cell Lung Cancer (SCLC): A Systematic Review of Health-Related Quality of Life (HRQoL) Literature Background:Little is known about the humanistic burden of small cell lung cancer (SCLC), specifically the impact on health-related quality of life (HRQoL)... BM ...
This article reviews literature published on new cytostatic drugs for the treatment of non-small cell lung cancer, covering the period from January 1993 until June 1995. Further experience with the nitrosourea derivative fotemustine has demonstrated this compound to be moderately active in NSCLC, ...